Commencement of Dermatological Clinical Trials
Filed with ASX · · 2 pages · English
Earlier from Argent Biopharma
- European CPNP Approval Granted for Derma Products
- MXC Operations Update
- New Panax Acquisition Agreement Signed, Settlement Imminent
- First Major European Sales and Revenue for MGC Derma Range
- Cleansing Prospectus
Later from Argent Biopharma
- Panax Acquisition Completed
- Medical Cannabis Clinical Study Commencing
- Cannabinoid Extraction Facility On Target Q2 Production
- Australian Legislation Changes Fast Track MXC
- Placement of $10m Closed Significantly Oversubscribed
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma